Amikacin

Showing 1 posts of 1 posts found.

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017
Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …

The Gateway to Local Adoption Series

Latest content